<DOC>
	<DOCNO>NCT01119235</DOCNO>
	<brief_summary>A new tablet form PF-04531083 manufacture . Previously compound administer solution/suspension healthy volunteer . This study investigate pharmacokinetics PF-044531083 tablet form compare pharmacokinetics obtain , dose regimen , solution/suspension .</brief_summary>
	<brief_title>A Study To Observe The Performance Of A Tablet Form Of PF-04531083 As Evidenced By The Concentration Of PF-04531083 In The Blood With Time Following Oral Administration To Healthy Volunteers .</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<criteria>Young Healthy volunteer Elderly volunteer Patients exist medical condition consider likely impinge study execution</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>tablet performance</keyword>
	<keyword>healthy volunteer</keyword>
	<keyword>open label</keyword>
</DOC>